IRIS
RAMELLA, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.406
NA - Nord America 1.537
EU - Europa 1.227
SA - Sud America 402
AF - Africa 51
OC - Oceania 15
Totale 13.638
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 8.619
US - Stati Uniti d'America 1.450
CN - Cina 870
HK - Hong Kong 520
IT - Italia 507
BR - Brasile 311
VN - Vietnam 209
GB - Regno Unito 203
DE - Germania 168
NL - Olanda 88
EE - Estonia 57
FI - Finlandia 49
IN - India 49
CA - Canada 48
AR - Argentina 36
ID - Indonesia 35
ZA - Sudafrica 26
MX - Messico 23
EC - Ecuador 18
TR - Turchia 18
UA - Ucraina 18
AT - Austria 17
FR - Francia 17
JP - Giappone 15
SE - Svezia 15
CZ - Repubblica Ceca 14
BD - Bangladesh 13
AU - Australia 12
ES - Italia 12
PL - Polonia 11
RU - Federazione Russa 11
CO - Colombia 9
PE - Perù 8
RO - Romania 8
IQ - Iraq 7
CL - Cile 6
LT - Lituania 6
CH - Svizzera 5
TW - Taiwan 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
EG - Egitto 4
KZ - Kazakistan 4
MA - Marocco 4
NP - Nepal 4
PY - Paraguay 4
UZ - Uzbekistan 4
BE - Belgio 3
OM - Oman 3
PH - Filippine 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
VE - Venezuela 3
AF - Afghanistan, Repubblica islamica di 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CM - Camerun 2
DK - Danimarca 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SV - El Salvador 2
TN - Tunisia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
KI - Kiribati 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MR - Mauritania 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
Totale 13.628
Salva come PNG Salva come JPEG
Città #
Singapore 603
Hong Kong 454
Hefei 396
Ashburn 380
Dallas 212
Boardman 197
Beijing 174
London 173
Rome 151
Shanghai 137
Munich 103
Ho Chi Minh City 87
Council Bluffs 77
Los Angeles 61
Hanoi 43
Amsterdam 38
San Francisco 36
Turku 28
Pune 26
São Paulo 26
Washington 26
Seattle 25
Milan 23
Naples 23
Toronto 22
Helsinki 21
Chicago 19
New York 19
Santa Clara 17
Brooklyn 16
Boston 12
Brno 12
San Jose 12
Atlanta 11
Haiphong 11
Montreal 11
Sona 11
Johannesburg 10
Mexico City 10
Rio de Janeiro 10
Stockholm 10
Tokyo 10
Warsaw 10
West Jordan 10
Charlotte 9
Palermo 9
Quito 9
Bologna 8
Nuremberg 8
Biên Hòa 7
Florence 7
Lima 7
Manaus 7
Phoenix 7
Ankara 6
Chennai 6
Curitiba 6
Da Nang 6
Frankfurt am Main 6
Hanover 6
Redmond 6
Bogotá 5
Brasília 5
Buenos Aires 5
Buffalo 5
Denver 5
Guarulhos 5
Guayaquil 5
Hải Dương 5
Jakarta 5
Jinan 5
Melbourne 5
Rocca di Papa 5
Santo André 5
Vicenza 5
Cascina 4
Guangzhou 4
Haikou 4
Hortolândia 4
Manchester 4
Montevideo 4
Ninh Bình 4
Porto Alegre 4
Providence 4
Salvador 4
Tashkent 4
Thái Bình 4
Thái Nguyên 4
Umeå 4
Vienna 4
Andover 3
Aprilia 3
Bangkok 3
Baoding 3
Belo Horizonte 3
Bergamo 3
Boydton 3
Campina Grande 3
Canberra 3
Castelfranco Veneto 3
Totale 4.043
Salva come PNG Salva come JPEG
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 301
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium 292
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 243
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 234
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 217
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial 210
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 209
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 207
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 205
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 203
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 202
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 201
Exploring Deep Pathomics in Lung Cancer 199
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 195
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 195
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 195
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 195
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 194
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 192
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 190
Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports 189
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 189
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 189
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort 187
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 187
A morphing technique to estimate lung cancer deformation due to breathing in radiotherapic treatment 187
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 182
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 181
Preventing Cardiotoxicity in Personalized Breast Irradiation 177
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 176
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 172
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 150
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 132
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 119
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 112
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 110
Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab 109
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 108
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 107
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 107
Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma 106
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 105
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. 104
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 104
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 103
Evaluating GANs in Medical Imaging 101
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 101
MR imaging of rectal cancer before and after chemoradiation therapy 101
Laparoscopic total mesorectal excision (L-TME) for rectal cancer surgery: Does elective diverting ileostomy really protect? An observational retrospective cohort study 100
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 100
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 100
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 99
A deep learning approach for overall survival prediction in lung cancer with missing values 98
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 97
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 97
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 96
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 95
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 93
Can we prevent COVID-19 from causing victims among uninfected cancer patients? 92
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 92
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 90
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 88
Chemoradiation for stage III non-small cell lung cancer 86
Design and evaluation of a methodology to perform personalized visual biofeedback for reducing respiratory amplitude in radiation treatment 86
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer 85
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 84
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 80
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 75
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 72
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 71
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 69
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? 68
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 67
Precision radiotherapy by SPECT lung functional imaging in NSCLC 49
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 48
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 47
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 44
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 42
Protective Role of Natural Compounds under Radiation-Induced Injury 40
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 40
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 38
Evidence-Based Radiotherapy: “Hot Topics” 2010 NSCLC 38
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 37
Stage III NSCLC treatment options: too many choices 36
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 36
Radiation therapy of breast cancer. Reasoned approach to a clinical case 36
Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma. 35
Il trattamento radioterapico del Mesotelioma Pleurico 35
The first survey on defensive medicine in radiation oncology 35
Gemcitabine and radiotherapy 34
Locally advanced NSCLC: how to improve disease control? 34
Multimodality treatment in locally advanced non-small cell lung cancer 33
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 32
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 32
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 31
The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. 31
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report. 31
Role of PSA levels and pathological stadiation before radiation therapy in predicting mp-MRI results in patients with prostate cancer recurrence after radical prostatectomy 30
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes 30
Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer 30
Totale 11.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 6 6 5 1 3 6 6 13 7 0 168
2022/2023172 1 1 2 8 8 1 24 6 74 0 38 9
2023/2024592 21 62 36 35 60 251 14 36 4 22 11 40
2024/20259.995 96 48 221 64 113 219 153 34 522 725 3.591 4.209
2025/20262.781 614 325 483 740 294 325 0 0 0 0 0 0
Totale 13.761